Tracking Middle Meningeal Artery Embolization for Brain Bleeding
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This study follows patients with chronic subdural hematoma (a type of bleeding around the brain) who receive a procedure called middle meningeal artery embolization, which reduces blood flow to prevent rebleeding. Researchers will track your recovery with imaging and clinical assessments to understand how well this treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with chronic subdural hematoma, confirmed by CT or MRI scan
- You are planning to have or have already had middle meningeal artery embolization (a catheter-based procedure to block blood vessels)
- You are 18 years or older
- You can participate in follow-up appointments, CT scans, and phone interviews over several months
- You have a stable living situation and can be reached by phone for check-ins
- You are willing to provide written consent and complete all study assessments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a procedure called middle meningeal artery embolization for people with a confirmed chronic subdural hematoma (a long-lasting bleed near the brain). It may help by reducing the blood supply to the area and improving symptoms after symptoms start or worsen.
This trial tests a new technique during surgery for chronic subdural haematoma (bleeding between the brain and skull) where doctors use heat or special tools to seal a blood vessel (the middle meningeal artery) to help prevent the bleed from returning. The goal is to see if this addition to standard surgery is safe and feasible.
This study tests a new way to treat chronic subdural hematomas (a type of bleeding on the brain) by using a very thin tube to seal off a small artery inside the head. This may help the blood clot shrink without needing a traditional surgery.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
This trial looks at how well a procedure called middle meningeal artery embolization works for people with chronic subdural hematoma (a collection of old blood on the brain's surface). It uses specific materials to block the blood supply to the hematoma, which may help the body reabsorb it without surgery.
Hear when a new Chronic Subdural Hematomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.